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Abstract
Background: Infection-inflammation combined with hypoxia-ischemia (HI) is the most prevalent pathological
scenario involved in perinatal brain damage leading to life-long neurological disabilities. Following
lipopolysaccharide (LPS) and/or HI aggression, different patterns of inflammatory responses have been uncovered
according to the brain differentiation stage [Brochu et al.: J Neuroinflammation 8:55, 2011]. In fact, LPS pre-exposure
has been reported to aggravate HI brain lesions in post-natal day 1 (P1) and P7 rat models that are respectively
equivalent - in terms of brain development - to early and late human preterm newborns. However, little is known
about the innate immune response in LPS plus HI-induced lesions of the full-term newborn forebrain and the
associated neuropathological and neurobehavioral outcomes.
Methods: An original preclinical rat model has been previously documented for the innate neuroimmune response
at different post-natal ages [Brochu et al.: J Neuroinflammation 8:55, 2011]. It was used in the present study to
investigate the neuroinflammatory mechanisms that underline neurological impairments after pathogen-induced
inflammation and HI in term newborns.
Results: LPS and HI exerted a synergistic detrimental effect on rat brain. Their effect led to a peculiar pattern of
parasagittal cortical-subcortical infarcts mimicking those in the human full-term newborn with subsequent severe
neurodevelopmental impairments. An increased IL-1β response in neocortical and basal gray neurons was
demonstrated at 4 h after LPS + HI-exposure and preceded other neuroinflammatory responses such as microglial
and astroglial cell activation. Neurological deficits were observed during the acute phase of injury followed by a
recovery, then by a delayed onset of profound motor behavior impairment, reminiscent of the delayed clinical
onset of motor system impairments observed in humans. Interleukin-1 receptor antagonist (IL-1ra) reduced the
extent of brain lesions confirming the involvement of IL-1β response in their pathophysiology.
Conclusion: In rat pups at a neurodevelopmental age corresponding to full-term human newborns, a systemic
pre-exposure to a pathogen component amplified HI-induced mortality and morbidities that are relevant to human
pathology. Neuronal cells were the first cells to produce IL-1β in LPS + HI-exposed full-term brains. Such IL-1β
production might be responsible for neuronal self-injuries via well-described neurotoxic mechanisms such as IL-1β
-induced nitric oxide production, or IL-1β-dependent exacerbation of excitotoxic damage.
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Introduction
Hypoxia-ischemia (HI) and/or infection-inflammation are
the principal risk factors of perinatal cerebral injuries in
both term and preterm human newborns [1-5]. However,
clinical and pathological features of human perinatal brain
lesions display striking variations according to the gesta-
tional ages [2]. Variations of brain damage according to
gestational age have been also reported in newborn ro-
dents exposed to HI [6,7]. In fact, distinct neuropatho-
logical signatures have been noticed depending on HI
timing. HI exposure of rats at post-natal day 1 (P1) corre-
sponding to the human early preterm stage of brain devel-
opment results in multifocal white-matter lesions [6]. In
contrast, HI exposure of rats at P7 or P12 corresponding
respectively to the late preterm and full-term human brain
stages of development results in severe parasagittal
cortico-subcortical infarcts [6]. Recent human epidemio-
logical and experimental studies highlighted that HI per se
was not involved as frequently as thought in perinatal
brain damage [1,3]. Infection-inflammation complicated
by a transient HI is one of the most common physiopatho-
logical scenarios encountered in human perinatal brain in-
sults and subsequent neonatal encephalopathy, leading to
cerebral palsy [1,8]. Such combination of infection/inflam-
mation and HI has been experimentally reproduced in ro-
dents at neurodevelopmental stages equivalent to early
and late preterm human neonates (rat pups at P1 and P7)
[9-11]. It has also recently been reproduced in rats at a
neurodevelopmental stage (P12) corresponding to full-
term human neonates and profound differences have been
shown between patterns of innate immune responses at
P1 and P12 [12]. In the present study, our aim was to
further characterize the neuroinflammatory mechanism
that underlines neurological impairments after pathogen-
induced inflammation and HI in term newborns.
Materials and methods
P12 rat model
The preclinical model was slightly modified from the
protocol recently published by our group [12]. Briefly,
Lewis dams were obtained from Charles River Labora-
tories (Saint-Constant, QC, Canada) at gestational day
16 (G16). They were kept at 20°C with a 12-h day/12-h
night cycle, had unlimited access to food and water, and
gave birth naturally. Pups were left untouched until P12
when they were given a single intraperitoneal injection
of lipopolysaccharide (LPS) (200 μg/kg diluted in 50 μL
of saline) or saline. Four hours after the LPS or saline in-
jection, ischemia was induced by a permanent ligature of
the right common carotid artery under isoflurane. A
heating mat was used to maintain the pups' temperature
at 37°C. A control group (Ctl) underwent no surgery or
sham surgery, during which the common carotid artery
was exposed but not ligated. Pups were returned to their
Table 1 List and features of antibodies
Antibody Company – reference
number
Dilution
Anti-DIG-AP Roche - 11093274910 1:3,000
Anti-NeuN Millipore – MAB377 1:100
Anti-Iba-1 Abcam - ab15690 1:200
Anti-GFAP Millipore - AB5541 1:500
Anti-PMN Cedarlane - CLAD51140 1:200
Anti-IL-1β Serotec - AAR15G 1:250
Anti-TNF-α Millipore - AB1837P 1:250
Anti-rabbit-HRP Serotec - STAR54 1:100
Anti-rabbit-Alexa Fluor
conjugated
Invitrogen - A11012 1:500
Anti-mouse-Alexa Fluor
conjugated
Invitrogen - A11005 1:500
Anti-chicken-Alexa Fluor
conjugated
Invitrogen - A11039 1:500
Figure 1 Pup mortality during hypoxia and weight chart of the
surviving pups. (A) Mortality (%) according to hypoxia duration in
lipopolysaccaride (LPS) ± hypoxia-ischemia (HI)-exposed pups (20 to
150 pups per condition). Χ2 test: ***P ≤ 0.001. (B) Pup-weight follow
up from post-natal day (P)12 to P20 (10 to 30 pups per condition
and time point). Mean ± standard error of the mean; analysis of
variance with Newman-Keuls post-test; *P ≤0.05, **P ≤ 0.01,
****P ≤ 0.0001. h hour, g gram, NS Not significant.
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dams for 30 minutes before being put in a hypoxia
chamber with 8% oxygen at 37°C for 1.5 h or 3 h ± 30
minutes. Pups from each litter were randomized into dif-
ferent experimental groups independently of their sex
and weight. The end of hypoxia was referred to 0 h.
Pups were sacrificed at 4 h (P12), 24 h (P13), 48 h (P14),
and 8 days (P20) post-HI. All the experiments were
performed with the full approval of the Comité d’éthique
de la Faculté de Médecine de l’Université de Sherbrooke.
Mechanistic experiments testing the role of IL-1β
IL-1 receptor antagonist (IL-1ra) was used at a concen-
tration of 200 mg/kg. This dose has already been dem-
onstrated to be the most successful in an adult model of
stroke [13]. The first injection was given 30 minutes be-
fore the LPS injection and five further injections were
given every 12 h thereafter.
Histology
Forebrains were fixed in 4% paraformaldehyde (PFA) at
room temperature, paraffin-embedded, and cut into
5-μm slices using a microtome, for histological studies.
H&E staining was used to visualize and quantify brain
lesions. Image J analysis software (National Institutes of
Health (NIH) Image, http://rsbweb.nih.gov/nih-image/)
was used to measure the surface of the right hemisphere
on coronal sections located at the epicenter of the infarct
(Bregma −1.00). The surfaces of the right hemisphere of
LPS- and/or HI-exposed rats were then compared with
those of the Ctl.
Immunohistochemistry (IHC) and immunofluorescence (IF)
IHC and IF were performed as previously described [9].
The antibodies used are detailed in Table 1. IF slides
were mounted using a 4',6-diamidino-2-phenylindole
(DAPI)-containing medium (Invitrogen, Burlington,
ON, Canada). Negative controls consisted of an add-
itional set of sections treated similarly but without the
primary antibody. Counting of labeled cells was per-
formed using the Image J analysis software (NIH Image,
http://rsbweb.nih.gov/nih-image/).
In situ hybridization
The expression and localization of mRNA encoding for
IL-1β was detected on brain sections using dioxigenin-
UTP(DIG)-labeled riboprobes. The IL-1β DNA template
was amplified using primers with specific restriction en-
zymes: IL-1β Bam HI forward 5’- AGT CCT GGA TCC
ATG GCA ACT GTC CCT GAA CT -3’ and IL-1β EcoRI
reverse 5’- GGC CGC GAA TTC AGC TCA TGG AGA
ATA CCA CT-3’. DIG-labeled single-stranded RNA was
transcribed from commercially available plasmid vectors
following the manufacturer instructions (Roche, Quebec,
QC, Canada). The in situ hybridization protocol was pro-
vided by Dr Jasna Kriz [14]. Briefly, slides were dried,
post-fixed in 4% PFA and digested by proteinase K, after
Figure 2 Quantification of lipopolysaccharide (LPS) + hypoxia-ischemia (HI)-induced brain damage at post-natal day (P)20. (A) Cavitary
damage (arrows) and ventricle enlargement (*) within the right hemisphere ipsilateral to HI in LPS + HI-exposed pups. (B) Mean ± standard error
of the mean forebrain weight loss (fold decrease compared to control (Ctl)), and (C) right hemisphere surface (mm2) after LPS ± HI-exposure
(4 to 6 pups per experimental condition). Analysis of variance with Newman-Keuls post-test; *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001. h hour.
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which the brain sections were rinsed in water and in a
solution of 0.1 M triethanolamine (TEA, pH 8.0) and acet-
ylated in 0.25% acetic anhydride in 0.1 M TEA. The
hybridization of the brains sections by the riboprobe was
done overnight at 72°C. Slides were rinsed in standard sa-
line citrate (1XSSC: 0.15 M NaCl, 15 mM trisodium citrate
buffer, pH 7.0). Slides were incubated with anti-DIG-AP
antibodies overnight at 4°C. Slides were incubated with
Figure 3 Astrocyte and macrophage/microglia in the right cerebral hemisphere. Percentages of macrophage/microglia (ionized
calcium-binding adapter molecule, 1Iba-1+) and astrocyte (Glial fibrillary acidic protein (GFAP)+) after lipopolysaccharide (LPS) +
hypoxia-ischemia (HI)-exposure versus control (Ctl) at 4 h (A) and 48 h (C). (B) Immunofluorescence (IF) staining for Iba-1+ cells in the right
fronto-parietal neocortex at 4 h. (D) IF staining for Iba-1+ and GFAP + cells in the right external capsule and fronto-parietal neocortex exposed
to LPS plus HI versus Ctl (3 to 4 pups per experimental condition). Scale bar = 50 μm. Mean ± standard error of the mean; analysis of variance
with Newman-Keuls post-test, *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001. h hour, F-P Fronto-parietal.
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nitro blue tetrazolium chloride (NBT)/(5-bromo-4-chloro-
1H-indol-3-yl) dihydrogen phosphate (BCIP) solution for
color development at room temperature for 16 h. Slides
were rinsed and mounted with mounting medium. The
staining intensities of IL-1β mRNA were studied by colori-
metric analysis performed with Image J software as previ-
ously described [12].
Brain magnetic resonance imaging (MRI) of the brain
MRI was performed on anesthetized rats at P20 using a
small-animal 7 T MRI system (Varian, Palo Alto, CA,
USA) equipped with 205/120. Magnex gradient coils and a
40-mm radiofrequency volume coil. The animals’ vital
signs and temperature were monitored throughout the
MRI procedure (Small Animal Instruments, Stony Brook,
NY, USA). T2-weighted respiration-gated images were ac-
quired using a fast spin-echo pulse sequence (TR/TEeff:
2,000/48 ms, 8 echoes, field of view (FOV): 2.5 × 2.5 cm2,
matrix: (256)2, NA: 8, 20 slices of 1.0 mm). Lesion volumes
were calculated using ITK-snap [15] and a three-
dimensional model using Owl developed by plateforme
d’analyse et de visualisation d’images (PAVI) at the
Université de Sherbrooke.
ELISA
Protein extracts were prepared from the right hemi-
sphere of the forebrain as previously described [12].
ELISA was performed on these protein extracts using
ELISA Kits (R&D Systems, Minneapolis, MN, USA), as
previously described [12].
Animal behavioral tests
The circling behavioral test was analyzed using the open-
field test apparatus. Rat pups at P13 and P14 were placed
in the center of the open field and videotaped for 1.5 mi-
nutes. The movement of the pups was scored: 0 = absence
of circling, 1 = partial circling, 2 = total circling. The open
field test was used to determine spontaneous locomotor
activity and exploratory behavior from P15 to P25 and
from P100 to P120, as described previously [9]. Motor bal-
ance and agility were also analyzed by the rotarod test
from P30 to P40, as previously described [9]. The elevated
body swing test was used to determine long-term motor
impairment from P100 to P120. The movement of the rats
suspended by their tail was captured by a camera. We set
the threshold at an angle of 90° for an efficient upswing.
Latency before the first upswing, the side of the upswing,
and the total number of upswings were recorded and
compared under different experimental conditions. The
turning-in-alley test was performed at P100-120 to assess
a potential persisting shift of lateralization due to motor
impairment. Rats were placed facing the end of a closed
alley: the duration and the side of the turning were
recorded.
Data analysis
Data are presented as mean ± standard error of the mean
(SEM). Comparisons between different conditions were
performed using analysis of variance (ANOVA) with
Newman-Keuls post-test or the unpaired t-test with the
Welch correction. The statistical significance level was set
at P ≤ 0.05. Mortality was analyzed with the X2 test. Data
from saline-injected pups with sham surgery, or no surgery,
Figure 4 Infiltration of polymorphonuclear neutrophils (PMN) in the right fronto-parietal neocortex exposed to lipopolysaccharide
(LPS) plus hypoxia-ischemia (HI) at 48 hours. (A) Mean ± standard error of the mean percentage of PMN infiltration after LPS + HI-exposure
versus control (Ctl) at 48 h. (B) Immunohistochemical staining of PMN (arrows) in the fronto-parietal neocortex of LPS + HI-exposed rats versus
Ctl, at 48 h (5 to 6 pups per condition). Scale bar = 50 μm. Unpaired t-test with Welch correction; ***P ≤ 0.001. h hour, F-P Fronto-parietal.
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Figure 5 (See legend on next page.)
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as well as male and female data were combined because
they were not significantly different.
Results
Mortality and weight loss induced by LPS and/or HI
Combination of LPS plus HI stimulation induced the
highest mortality, peaking after 3 h of hypoxia (Figure 1A).
A transient lack of weight gain was observed under LPS +
HI treatment after 1.5 h of hypoxia (Figure 1B).
Neuropathological alterations induced by LPS and/or HI
Brain damage induced by HI and by LPS + HI was ipsilat-
eral to the right common carotid occlusion. In the right
cerebral hemispheres from LPS + HI-exposed animals in-
farcted areas appeared as confluent microcystic or large
cavitary lesions, significantly more extended compared to
HI exposure alone (Figure 2A and [12]). Forebrain weights
were significantly reduced at 8 days (P20) post-HI (0.89-
fold after 3 h of hypoxia), and post-LPS plus HI (0.9-fold
and 0.77-fold respectively after 1.5 h or 3 h of hypoxia),
compared to Ctl. Maximal forebrain weight loss was found
after LPS + HI exposure (Figure 2B) compared to HI or
LPS exposure alone. The brains of LPS + HI-exposed pups
also displayed a significantly reduced surface of the right
hemisphere compared to other experimental conditions
(Figure 2C). Brains exposed to LPS alone did not show
any histological change compared to Ctl (data not shown).
Given the high mortality induced by 3 h of hypoxia
(Figure 1A), we decided to conduct our following experi-
ments under 1.5 h of hypoxia. We further investigated the
LPS + HI condition because, in contrast to HI alone, it has
never been studied before at the P12 term-like develop-
mental stage, except for comparing the overall cytokine
and chemokine production within the brain, between P1
and P12 rats [12]. After LPS + HI, a rapid increase of ion-
ized calcium-binding adapter molecule 1 (Iba-1) + micro-
glia/macrophages was observed in the right neocortex
compared to Ctl at 4 h (18-fold increase) and at 48 h
(13-fold increase); Iba-1+ macrophage/microglia infiltra-
tion was delayed - appearing only at 48 h - in the under-
lying external capsule (8-fold increase) (Figure 3A-D) and
in the right caudate putamen (data not shown). Glial fibril-
lary acidic protein (GFAP) + astrocyte significantly in-
creased at 48 h (not at 4 h) in the right neocortex of
LPS + HI-exposed pups (11-fold increase), the underlying
external capsule (1.6-fold increase) and in the caudate puta-
men (data not shown) compared to Ctl (Figure 3A, C, D).
Polymorphonuclear neutrophil (PMN) infiltration was ab-
sent at 4 h post-LPS plus HI but significantly increased
later (at 48 h), in the infarcted neocortical areas, compared
to Ctl (Figure 4A, B). No histological change was noticed in
the left hemisphere from animals exposed to LPS + HI
(data not shown).
Early (4 h) and strong IL-1β response from neocortical
and deep gray neurons, spreading to astrocytes of gray
and white matter at 48 h, in rat forebrains after exposure
to LPS plus HI.
ELISA results demonstrated an early increase in IL-1β
after 4 h LPS + HI-exposure compared to Ctl (183.7 ver-
sus 69.5 pg/mg) (Figure 5A). On in situ labeling by IHC
and IF, neuronal nuclei (NeuN)-positive neocortical and
caudateputamen neurons were the only cell types in the
(See figure on previous page.)
Figure 5 Neuronal expression of IL-1β in the right hemisphere exposed to lipopolysaccharide (LPS) + hypoxia-ischemia (HI). Mean ±
standard error of the mean (SEM) (pg/mg) of IL-1β (A) and TNF-α (B). Titrations were done by ELISA on total protein extracts from the right cerebral
hemisphere exposed to LPS plus HI for 4 h to 24 h compared to control (Ctl). (C) Immunofluorescent staining of neuronal nuclei (NeuN) + IL-1β + cells
in the fronto-parietal neocortex (D). Mean ± SEM (%) of neural cells expressing Il-1β. (E) Immunohistochemical staining of IL-1β expression on neurons
(arrows) from fronto-parietal neocortex and caudate putamen at 4 h post-LPS + HI compared to Ctl. Scale bar = 50 μm (4 to 6 pups per experimental
condition). Analysis of variance with Newman-Keuls post-test; *P ≤ 0.05, **P ≤ 0.01. h hour, F-P Fronto-parietal, WM White matter, CPu Caudate
putamen, Iba1 Ionized calcium-binding adapter molecule 1, GFAP Glial fibrillary acidic protein.
Figure 6 IL-1β mRNA expression by in situ hybridization in the right hemisphere of lipopolysaccharide (LPS) + hypoxia-ischemia
(HI)-exposed brains versus control (Ctl). Absence of IL-1β mRNA detected in neurons from Ctl brains showing pure hematoxylin staining
(arrowhead) (A). High IL-1β mRNA expression (arrowhead) detected in neocortical (BI) and deep gray (BII) neurons 1 h after LPS + HI exposure
(B). Mean ± standard error of the mean IL-1β mRNA relative expression in gray matter of LPS + HI animals compared to Ctl (C) (3 animals per
experimental condition). Scale bar = 10 μm. Unpaired t-test with Welch correction; ****P ≤ 0.0001.
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brain with increased expression of IL-1β at 4 h after in-
farction (Figure 5C-E). This neuronal IL-1β expression
was also assessed at the mRNA level 1 h post LPS + HI
with in situ hybridization (Figure 6A, B). A 12-fold IL-1β
mRNA expression was detected in all neurons from neo-
cortical and deep gray areas subjected to damage, com-
pared to Ctl (Figure 6C). IL-1β immunoreactivity was
located in cellular bodies of fronto-parietal neurons from
all six right neocortical layers of ongoing infarcted areas
(Figure 5C). In fact, double staining on IF showed no sig-
nificant difference in the proportion of IL-1β + GFAP +
astrocytes and IL-1β + Iba-1+ microglia/macrophages be-
tween Ctl and LPS plus HI in the neocortex, white matter
and striatum (Figure 5D, 7A). At 48 h, IL-1β expression
was mainly present in neocortical neurons (data not
shown). There was also a 4-fold increase in the percentage
Figure 7 Astroglial and macrophage/microglial expression of IL-1β in the right hemisphere exposed to lipopolysaccharide (LPS) +
hypoxia-ischemia (HI). Mean ± standard error of the mean ratio of Glial fibrillary acidic protein (GFAP) + IL-1β + or ionized calcium-binding
adapter molecule 1 (Iba-1) + IL-1β + double-positive cells to total number of cells after LPS + HI exposure at 4 h (A) and 48 h (B) compared to
control (Ctl). Immunofluorescent staining of GFAP + IL-1β + double-positive cells (overlap) in the fronto-parietal neocortex (C) and external
capsule (D) at 48 h post-LPS + HI versus Ctl (3 to 4 pups per experimental condition). Scale bar = 50 μm. Analysis of variance with Newman-Keuls
post-test; *P ≤ 0.05, ***P ≤ 0.001. h hour, F-P Fronto-parietal, DAPI 4',6-diamidino-2-phenylindole.
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of IL-1β + GFAP + astrocytes - but not in IL-1β + Iba-1+
microglia/macrophage staining - within infarcted neocor-
tical, white matter and caudate putamen areas of LPS +
HI-exposed rats compared to Ctl (Figure 7B-D).
Early and weak TNF-α production in microglial cells in
forebrains of LPS plus HI exposed rats
After LPS + HI exposure, a weak level of TNF-α expression
(20-fold lower than IL-1β) was detected by ELISA at 4 h to
24 h post-HI (4 pg/mg at 4 h) compared to Ctl (0.02 pg/
mg at 4 h) (Figure 5B). At 4 h post-HI, IF double-staining
showed an increase in the number of TNF-α + Iba-1 +
microglia/macrophage in the gray matter (neocortex and
striatum) of LPS + HI-exposed rats (Figure 8A). At 48 h,
an increase of TNF-α + Iba-1+ microglia/macrophages was
noticed in both fronto-parietal lesioned gray and white
matters, whereas the number of TNF-α + GFAP + cells
were moderately increased only in the gray matter areas
(Figure 8B, D, and E). There was no neuronal immunore-
activity for TNF-α at any time point (data not shown).
Motor behavioral impairments in LPS + HI-exposed
juvenile and adult rats
Right or left circling behavior was transiently observed
during the acute post-stroke phase at P13 to P14, in LPS +
HI-exposed rats but not in Ctl (Figure 9A). The spontan-
eous locomotor activity recorded from P15 to P25 in the
open-field test was similar in both Ctl and exposed rats
(Figure 9B). The rotarod test at P30 showed decreased
agility of LPS + HI-exposed rats compared to Ctl
(Figure 9C). At the adult age (P100), the elevated body
swing and open-field tests showed an overall decrease of
spontaneous and forced motor activity in LPS + HI-
treated rats compared to Ctl rats (Figure 10A, B). LPS +
HI-exposed rats were significantly slower than Ctl to up-
swing (Figure 10B) and travelled a shorter distance
(Figure 10A). Finally, a change in lateralization was ob-
served with the turning-in-alley test for exposed rats: Ctl
had a slight tendency to turn right (55%) whereas 70% of
LPS plus HI-exposed rats turned left (Figure 10C).
Effect of IL-1ra on LPS + HI induced brain damage
Brain lesions were observed by MRI 8 days (P20) after
LPS + HI. A wide hyper-signal area associated with the
lesions was observed in the right cortex (Figure 11A, C).
The treatment with IL-1ra decreased the extent of this
area (Figure 11A, C). The total lesion volume decreased
from 76.7 ± 11.7 mm3 to 17.5 ± 2.4 mm3 after IL-1ra
treatment (Figure 11B).
Discussion
The compounding effect of both LPS and HI on brain
lesions had been previously reported in animal models
of early and late preterm neonates [9,16]. This is the first
report of neuropathological and behavioral outcomes of
an animal model reproducing one of the most frequent
pathological scenarios happening in the term human
newborn context, namely pathogen exposure followed
(See figure on previous page.)
Figure 8 Astroglial and macrophage/microglial expression of TNF-α in the right hemisphere exposed to lipopolysaccharide (LPS) +
hypoxia-ischemia (HI). Mean ± standard error of the mean ratio of Glial fibrillary acidic protein (GFAP) + TNF-α + or ionized calcium-binding
adapter molecule 1 (Iba-1) + TNF-α + double-positive cells on total number of cells after 4 h (A) and 48 h (B). Immunofluorescent (IF) staining of
Iba-1+ TNF-α + double-positive (overlap) cells within fronto-parietal neocortex at 4 h (C) and 48 h (D) after LPS + HI versus control (Ctl). IF
staining of GFAP + TNF-α + double-positive (overlap) cells within fronto-parietal neocortex at 48 h (E) after LPS + HI versus Ctl (3 to 4 pups per
condition). Scale bar = 50 μm. Analysis of variance with Newman-Keuls post-test; *P ≤ 0.05, ***P ≤ 0.001, ****P ≤ 0.0001. h hour, F-P Fronto-parietal,
DAPI, 4',6-diamidino-2-phenylindole.
Figure 9 Motor behavioral impairments of lipopolysaccharide (LPS) + hypoxia-ischemia (HI)-exposed rats between post-natal day (P)14
and P40. (A) Mean ± standard error of the mean (SEM) travelled distance measured in the open-field test at P15 to P25 in LPS + HI-exposed pups
compared to control (Ctl). (B) Mean ± SEM latency to fall of LPS + HI-exposed rats versus Ctl in the rotarod test at P30 to P40. (C) Mean ± SEM score of
circling behavior at P14 in LPS + HI-exposed pups versus Ctl (10 to 14 pups per experimental condition). Unpaired t-test with Welch correction;
*** P ≤ 0.001. m meter, s second.
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by subsequent HI [1,8]. The LPS + HI-induced brain le-
sions observed in this P12 rat model consist of large in-
farcts affecting frontal and parietal neocortex as well as
adjacent subcortical white matter and caudate putamen.
These lesions were observed at the same areas revealed by
MRI. This neuropathological pattern is in sharp contrast
with the one generated by LPS + HI-exposures at P1, that
is, at a stage of brain development similar to a 26-week to
30-week premature human newborn [9,12,17]. In P1 pups,
LPS + HI triggered a combination of radial columns and
laminar foci of neocortical and caudate putamen neuronal
death associated with patchy periventricular white matter
loss, a typical pattern of the very premature human new-
born [9]. At P7 (equivalent to the cerebral development of
32-week to 34-week gestation human newborns), LPS +
HI-induced mixed patterns of P1 and P12 brain lesions by
combining both foci of infarcts and selective columnar
gray matter necrosis [6,7,16]. Thus, the differential impact
of LPS + HI on the rat brain at relatively close develop-
mental stages (P1 versus P7 versus P12) reflects the various
profiles of brain damage observed in human newborns,
stratified in their three principal stages of maturation,
namely early preterm, late preterm or full-term neonates.
The fact that brain lesions after LPS + HI-exposure at P12
are found in major cortical and subcortical motor centers
likely accounts for the motor behavioral abnormalities that
were demonstrated in this model, such as circling and
decreased agility [18]. In other rodent neonatal models
subjected to pure HI, transient hyperactivity has been
mainly observed after HI brain injury induced in P6-9 rats.
Nevertheless, eventual long-term behavioral impairments
have been rarely investigated, except in the HI-exposed
rabbit, which displayed symptoms of spasticity [19,20]. To
our knowledge, our model provides the first demonstration
of long-term motor impairments in rodents subjected to
post-natal exposure to LPS + HI. These findings are rele-
vant to cerebral palsy symptoms in humans [21]. However,
the lack of spastic or dystonic symptoms, associated with
the classic limitations of a rodent model (the level of neo-
cortical development, and its distinct implication in motor
control, compared to humans) should be mentioned [22].
Increased brain damage and mortality were observed in
rats when HI was combined with LPS, compared to HI
alone. One explanation could be that the transcription fac-
tor hypoxia-inducible factor (HIF)-1α may be activated by
both HI and LPS stimulation. HIF-1α activation leads to
pro-inflammatory cytokine up-regulation, thereby promot-
ing cellular phagocytosis in anaerobic conditions [19,23].
Systemic LPS administration also induces an immune re-
sponse in the brain through its direct interactions with
Toll-like receptor 4 (TLR-4) [24]. Interestingly, in micro-
glia and astrocytes, HI has been shown to indirectly acti-
vate the TLR-4 pathway through endogenous ligands, such
as heat-shock proteins [25]. Activation of TLR-4 triggers
Figure 10 Motor behavioral impairment of lipopolysaccharide (LPS) + hypoxia-ischemia (HI)-exposed rats at P100 to P120. (A) Mean ±
standard error of the mean (SEM) travelled distance measured in the open-field test in LPS + HI-exposed rats versus Ctl. (B) Mean ± SEM latency
to upswing in the elevated-body-swing test in LPS + HI-exposed rats versus control (Ctl). (C) Mean ± SEM left or right turn in the turning-in-alley
test in LPS + HI-exposed rats versus Ctl (8 to 10 rats per condition). Unpaired t-test with Welch correction; *P ≤ 0.05, ***P ≤ 0.001, ****P ≤ 0.0001.
m meter, s second.
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the Nuclear factor-κB (NF-κB) pathway, which is also acti-
vated by IL-1β and TNF-α [26]. NF-κB and HIF-1α are
pro-inflammatory transcription factors that operate con-
jointly within microglial and astroglial cells under the
combined activation with both LPS and HI. Pro-IL-1β has
to be cleaved by a macromolecular complex called infla-
mmasome so that the IL-1β secretion occurs [27]. Most of
the central nervous system cells, including neurons, as-
trocytes, and microglia, express cellular machinery to as-
semble inflammasome and therefore are able of IL-1β
secretion [28]. The exact nature of the inflammasome as-
sembling and triggering stimuli is unclear, but different
pathogen-associated molecular patterns (PAMPs) and
damage-associated molecular patterns (DAMPs) initiate
inflammasome-dependent IL-1β processing [27]. It de-
pends on the presence of different nod-like receptors
(NLRs) that are responsible for sensing intracellular milieu
and triggering inflammasome assembly [27]. It has been
shown that the inflammasome is activated after brain in-
jury [28]. NLRP1 and NLRP3 inflammasomes are present
in neurons and microglia respectively [28]. They both trig-
ger the activation of pro-IL-1β and are activated by
different PAMPs, such as LPS, and DAMPs that are
endogeneous molecules released after cellular damage. Ex-
posure to LPS and HI leads to the production of DAMPs
and, when combined, could lead to an exacerbated activa-
tion and secretion of IL-1β, possibly through NLRP1
inflammasome activation [28]. Such ability of neurons to
produce IL-1β mRNA and protein has also been shown by
previous studies using either rodents subjected to HI,
traumatic, and excitotoxic brain injuries, or samples of le-
sioned human perinatal brains [29-31]. Thus, exposure to
LPS + HI, at this specific term-like stage of brain develop-
ment, might be responsible for neuronal self-injuries via
IL-1β production through well-known neurotoxic mecha-
nisms, such as IL-1β-induced nitric oxide production, or
IL-1β exacerbation of excitotoxic damage [32]. Consistent
with this hypothesis, blocking the signaling pathway of IL-
1β in the presence of IL-1ra, decreased the extent of brain
injury in LPS + HI-exposed rats.
Conclusion
Overall, after LPS + HI, IL-1β is expressed mainly by
neurons at 4 h post-aggression and, later, by neurons
and microglial cells at 48 h. This expression exacerbates
neuroinflammation and cerebral injury resulting in
Figure 11 Protective effect of IL-1 receptor antagonist (IL-1ra) on lipopolysaccharide (LPS) + hypoxia-ischemia (HI)-induced brain
lesions. (A) Magnetic resonance imaging of LPS + HI-exposed rat brains ± treatment with IL-1ra. Arrowheads show the areas of damage. No
visible damage was observed in the left hemisphere. (B) Mean ± standard error of the mean lesion volume after LPS + HI exposition ± treatment
with IL-1ra. (C) Three-dimensional reconstruction of the lesion after LPS + HI ± IL-1ra (5 to 6 rats per condition). Unpaired t-test with Welch
correction; **P ≤ 0.01. R right side, mm3 cubic millimeters.
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delayed onset of profound motor impairments. Interfer-
ing with IL-1β signaling decreased the extent of brain
lesions.
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